Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections.
D000336:Aerosols; D000368:Aged; D001982:Bronchial Diseases / Q000209:etiology; D001984:Bronchial Neoplasms / Q000150:complications / Q000188:drug therapy; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000336:Aerosols; D002264:Carboxylic Acids; D010406:Penicillins; D013876:Thiophenes